WIN-Partners CoTSE:3183 +0.31%63 PB Ratio is 1.52 as of Jul. 09, 2026, which is 1% below its 10-year median of 1.54. GuruFocus rates TSE:3183 with a GF Score™ of 63/100 and a GF Value™ of 円1,522.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 110 Medical Distribution companies, WIN-Partners Co ranks worse than 61.82% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-09), WIN-Partners Co's share price is 円1285.00. WIN-Partners Co's Book Value per Share for the quarter that ended in Mar. 2026 was 円846.95. Hence, WIN-Partners Co's PB Ratio of today is 1.52.
Good Sign:
WIN-Partners Co Ltd stock PB Ratio (=1.47) is close to 2-year low of 1.34.
The historical rank and industry rank for WIN-Partners Co's PB Ratio or its related term are showing as below:
TSE:3183'
s PB Ratio Range Over the Past 10 Years
Min: 1.2 Med: 1.54 Max: 3.35
Current: 1.52
During the past 13 years, WIN-Partners Co's highest PB Ratio was 3.35. The lowest was 1.20. And the median was 1.54.
TSE:3183's PB Ratio is ranked worse than 61.82% of 110
companies
in the Medical Distribution industry
Industry Median: 1
vs TSE:3183: 1.52
During the past 12 months, WIN-Partners Co's average Book Value Per Share Growth Rate was 0.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 1.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of WIN-Partners Co was 24.00% per year. The lowest was 1.80% per year. And the median was 9.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
WIN-Partners Co PB Ratio Related Terms
WIN-Partners Co PB Ratio Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, WIN-Partners Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
WIN-Partners Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
WIN-Partners Co (TSE:3183) has a PB Ratio of 1.52 as of Jul. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on WIN-Partners Co and its competitors. This is near median its historical median of 1.54. Over the past decade, WIN-Partners Co's PB Ratio has ranged from 1.20 to 3.35. According to the industry distribution chart, WIN-Partners Co ranks #68 out of 110 companies in the Medical Distribution industry, placing it in the top 61.8%.
Is WIN-Partners Co's PB Ratio too high?
WIN-Partners Co's current PB Ratio of 1.52 is near median its 10-year median of 1.54. Over the past 10 years, this metric has ranged from a low of 1.20 to a high of 3.35. The Medical Distribution industry median PB Ratio is 1.00. WIN-Partners Co's value of 1.52 is 52% above this industry median. Based on the distribution chart, WIN-Partners Co ranks #68 out of 110 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's PB Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #68 out of 110 companies for PB Ratio. This places WIN-Partners Co in the lower half of its industry. The industry median PB Ratio is 1.00. WIN-Partners Co's value of 1.52 is 52% above this benchmark. Historically, WIN-Partners Co's own PB Ratio has ranged from 1.20 to 3.35 over the past decade. While the company's 10-year median is 1.54 vs. the industry median of 1.00, WIN-Partners Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.00, based on 110 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WIN-Partners Co's current PB Ratio of 1.52 is 52% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current PB Ratio is 1.52, which is near median its own 10-year median of 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current PB Ratio is 1.52, which is near median its 10-year median of 1.54 and 52% above the Medical Distribution industry median of 1.00. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current PB Ratio is 1.52 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
PB Ratio: 1.52 (near median its 10-year median of 1.54)
GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
Industry Position: 52% above the Medical Distribution median (#68 of 110)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score
Get the complete analysis for TSE:3183
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
